Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06789094

Validating the Ain Shams Cognitive Assessment Tool

Validating the Ain Shams Cognitive Assessment (ASCA) for Diagnosing Mild Cognitive Impairment and Dementia

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

The diagnosis of cognitive impairment, including dementia and mild cognitive impairment (MCI), is crucial for timely intervention and management. Various screening tools are available for assessing cognitive function, among which the Mini-Mental State Examination (MMSE), the Addenbrooke's Cognitive Examination (ACE), and the Montreal Cognitive Assessment (MoCA) are widely used. However, the recently developed Ain Shams University Cognitive Assessment (ASCA) has shown promise in detecting early cognitive decline. This study aims to assess the performance of ASCA in diagnosing cognitive impairment against DSM5 criteria.

Conditions

Interventions

TypeNameDescription
OTHERAin Shams University Cognitive Assessment (ASCA) toolThe ASCA, developed at Ain Shams University, is a comprehensive tool designed for cognitive assessment in Egyptian population. It encompasses various tests to assess cognitive functions and cultural understanding. These include the Verbal Paired Associated Test, evaluating verbal learning, distractor interval, delayed recall, and word recognition. The Bender Gestalt assesses visual-motor skills and memory. Short-term and working memory are tested through Digit Forward and Digit Backward Span Length tasks. Set Shifting is measured using a modified Trail Making Test, adapted for illiterates. Additionally, tests for letter/lexical fluency, verbal fluency, language object naming, abstraction, and judgment offer further insights into cognitive abilities and cultural interpretation.

Timeline

Start date
2025-02-01
Primary completion
2025-05-01
Completion
2025-06-01
First posted
2025-01-23
Last updated
2025-01-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06789094. Inclusion in this directory is not an endorsement.